Jubilant Pharmova subsidiary to appeal significant GST demand

Jubilant Pharmova Limited announced that its wholly-owned subsidiary, Jubilant Biosys Limited, received an adjudication order from the deputy commissioner of commercial taxes, Mysuru. The order confirms a demand for GST, interest, and penalty totaling over INR 11.6 crore for the financial year 2021-2022. Specifically, the demand includes GST of INR 6,64,82,025, interest of INR 4,31,78,702, and a penalty of INR 66,48,202.

The dispute primarily concerns issues related to the availment and reversal of input tax credit (ITC), alongside the denial of GST reduction benefits on credit notes issued by the company. Jubilant Biosys Limited maintains that the adjudication order is legally incorrect and intends to file a detailed appeal with the GST Appellate Authority.

Jubilant Pharmova expects no financial or operational impact from this development. The event occurred on December 4, 2025, and relevant documentation has been posted on the company's website.